Followers | 1290 |
Posts | 31382 |
Boards Moderated | 15 |
Alias Born | 10/18/2011 |
Wednesday, October 10, 2012 5:55:34 AM
Last update: 10/10/2012 5:00:00 AM
NOKOMIS, Fla., Oct 10, 2012 (BUSINESS WIRE) -- As Rainbow Coral Corp. (RBCC) nears the completion of a ground-breaking joint venture agreement with Amarantus BioSciences (AMBS), the market demand for a cure to Parkinson's disease grows stronger by the day.
Researchers believe that Parkinson's is caused by the destruction of cells in various parts of the brain, including the substantia nigra, where dopamine is produced. Without dopamine, the brain can't properly transmit signals that allow for coordinated movement. The Parkinson's Disease Foundation estimates that as many as one million Americans suffer from Parkinson's disease, and 60,000 new patients are diagnosed each year.
Parkinson's typically occurs in older people, and as the world's population ages, incidence of the disease is on the rise. To battle Parkinson's, more than 150 drugs are currently in the pipeline around the world--a majority of them in the pre-clinical stage. According to a recent report by Visiongain, the market for these drugs could grow to a value of $3.75 billion over the next three years.
RBCC and Amarantus plan to capitalize on this growth by commercializing a powerful new weapon in the fight against Parkinson's. The companies plan to work together to deliver NuroPro, a revolutionary new early-detection diagnostic blood test that could soon prove key to successfully treating Parkinson's and other neurological diseases. The PD application of this diagnostic has completed proof-of-concept and Phase I clinical validation studies.
For more information on Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., please visit .
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM